Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced ...
Q4 2025 Earnings Call February 5, 2026 8:30 AM ESTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor ...
MedPage Today on MSN
Trump Signs Bill With Major Reforms for Pharmacy Middlemen
Pharmacists, other healthcare stakeholders say PBM reforms "level the playing field" ...
Global health company The Cigna Group today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health ...
Midland Reporter-Telegram on MSN
Pfluger pushes for crackdown on pharmacy middlemen to lower drug costs
Rep. August Pfluger talks about the crackdown on pharmacy benefit managers and the need for greater drug price transparency.
President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking to ...
Consumers can buy more than 40 medicines direct from drugmakers at TrumpRx.gov ...
Rebate-centric formulary competition reportedly increased list prices, raising copays and coinsurance because patient ...
The Cigna Group reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health ...
Cigna (CI) stock gains as the company beats with Q4 2025 earnings and revenue even as its 2026 earnings outlook trails ...
By Sneha S K and Sriparna Roy Feb 5 (Reuters) - Cigna's fourth-quarter profit and revenue topped expectations, helped by ...
KFF Biden era law improves Medicare Part D coverage for high-cost drugs ahead of 2026 price negotiations, enhancing patient access nationwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results